Announcement PDF Appendix 3Y Change of Director’s Interest Notice Rule 3.19A.2 Appendix 3Y Change of Director’s Interest Notice Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public. Name of entity DOCTOR CARE ANYWHERE GROUP PLC ABN 645 163 873 We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act. Name of Director John Stier Date of last notice 15 January 2026 Part 1 – Change of director’s relevant interests in securities In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part. Direct or indirect interest Direct Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. N/A Date of change 16 June 2026 No. of securities held prior to change 4,000,000 Class Ordinary fully paid CDIs Number acquired 250,000 Number disposed 0 Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation Total consideration of AUD $32,500 (average AUD $0.13 per share) No. of securities held after change 4,250,000 Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back On market acquisition Appendix 3Y Change of Director’s Interest Notice + See chapter 19 for defined terms. Appendix 3Y - Page 1 of 2 Part 2 – Change of director’s interests in contracts Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part. Detail of contract N/A Nature of interest N/A Name of registered holder (if issued securities) N/A Date of change N/A No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed N/A Interest acquired N/A Interest disposed N/A Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation N/A Interest after change N/A Part 3 – +Closed period Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required? Yes If so, was prior written clearance provided to allow the trade to proceed during this period? Yes If prior written clearance was provided, on what date was this provided? 15 June 2026